CraigThomas MorganChepkeMDDFAPA(He/Him)

Psychopharmacology, Integrative Psychiatry

Private Practice Psychiatry at Excel Psychiatric Associates

Dr. Chepke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10225 Hickorywood Hill Ave
Suite B
Huntersville, NC 28078
Phone+1 704-457-9292

Fax+1 704-274-5783

Distinguished Fellow of the American Psychiatric Association American Psychiatric Association
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013

PubMed

Effect of Lemborexant on Daytime Functioning in Adults With Insomnia: Patient-Reported Outcomes From a Phase 3 Clinical Trial.
Craig Chepke, Kimberly A Cote, Kate Pinner, Jane Yardley, Christie Lundwall
The Primary Care Companion for CNS Disorders. 2025-01-16
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression.
Craig Chepke, Richard Shelton, Gerard Sanacora, Teodora Doherty, Palina Tsytsik
The International Journal of Neuropsychopharmacology. 2024-12-01
2 citations
Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Postt...
Rakesh Jain, Craig Chepke, Lori L Davis, Roger S McIntyre, Murray A Raskind
The Journal of Clinical Psychiatry. 2024-11-08

Teva to Present Latest Research from Neurology Portfolio at the 2022 American Psychiatric Association Annual MeetingMay 17th, 2022
Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and EpilepsyApril 16th, 2021
The Bystander: A First-Person Perspective on Being Blind to Tardive DyskinesiaFebruary 26th, 2019
Join now to see all